TP53 and neoplasm: In fact, when compared to cancer antigen 15-3, a prospective study by Dawson et al. demonstrated that ctDNA serum levels (sequenced for PIK3CA and TP53 mutations) were significantly more sensitive to changes in tumor burden [29].